Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786708 · ClinicalTrials.gov registry record
Sensitivity and Specificity of NGAL in an Emergency Room Population
A clinical trial of Renal Insufficiency, Chronic and Hydronephrosis, sponsored by Columbia University.
- Completed
- Registry status
- 2,304
- Enrollment target
- 3
- Study locations
NCT00786708 is a study of Renal Insufficiency, Chronic and Hydronephrosis that has completed, run by Columbia University. The registered enrollment target is 2,304 participants, above the 485-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (375% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT00786708, a study of Renal Insufficiency, Chronic and Hydronephrosis, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 2,304 participants
- Enrollment target
- 3
- Study locations
Study Summary
Hypothesis: In patients that present to an urban emergency room, a single urine neutrophil gelatinase-associated lipocalin (NGAL) measurement can classify their kidney disease as stable chronic kidney disease, acute tubular necrosis, urinary outlet obstruction or pre-renal azotemia.
Conditions Studied
Study Locations (3)
New York
- Columbia University Medical Center - New York
- Staten Island University Hospital - Staten Island
Other
- Charite University Medical Center - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,304 participants |
| Start Date | 2006-12 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786708
The ClinicalTrials.gov registry entry for NCT00786708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,304 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 485-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (375% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Renal Insufficiency, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT00786708 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.
Frequently Asked Questions
What is clinical trial NCT00786708 about?
NCT00786708 is a clinical study titled "Sensitivity and Specificity of NGAL in an Emergency Room Population". Hypothesis: In patients that present to an urban emergency room, a single urine neutrophil gelatinase-associated lipocalin (NGAL) measurement can classify their kidney disease as stable chronic kidney disease, acute tubular necrosis, urinary outlet obstruction or pre-renal azotemia.
What is the current status of trial NCT00786708?
This trial is currently completed. The enrollment target is 2,304 participants. The study started on 2006-12. Estimated completion is 2013-07.
What conditions does trial NCT00786708 study?
This clinical trial studies the following conditions: Renal Insufficiency, Chronic, Hydronephrosis, Renal Failure, Acute, Azotemia.
Who is sponsoring clinical trial NCT00786708?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00786708 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Insufficiency, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurovascular Transduction During Exercise in Chronic Kidney Disease
RECRUITING · Phase 2
-
Transformative Research in Diabetic Nephropathy 2.0
RECRUITING
-
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
RECRUITING · Phase 1
-
Penn Produce Prescription and Chronic Kidney Disease Study
ACTIVE NOT RECRUITING · NA
-
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
ACTIVE NOT RECRUITING
-
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.